A Spanish court denies a bid by Zeltiq and Mass. General Hospital to bar Clinipro from selling its allegedly infringement LipoCryo device.
Zeltiq (NSDQ:ZLTQ) said the Mercantile Court in Spain denied its bid for a preliminary injunction against Clinipro in a joint lawsuit filed with Mass. General Hospital against the French medical aesthetics company.
Zeltiq and MGH sued Clinipro last year in France and Spain, alleging infringement of 2 patents for its CoolSculpting device.
Zeltiq's CoolCurve+ enables physicians to "treat more body shapes" with its CoolSculpting targeted fat-destroying cooling process.
California-based medical technology company Zeltiq (NSDQ:ZLTQ) launched CoolCurve+, a new applicator platform for its CoolSculpting system to help physicians to "treat more body shapes."
Aesthetics devices maker Zeltiq appointed Mark Foley its president & CEO, a position he held in the interim following former CEO Gordie Nye's departure in April.
Zeltiq seals the deal with interim CEO
Revenues for aesthetic medical device companies largely rise during the 2nd quarter, as purchasing and volume growth trend up, according to a MassDevice.com analysis.
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn't necessarily translate into healthy bottom lines for all comers.
Mako Surgical reveals 6 shareholder lawsuits filed in the last 4 months over accusations of "misrepresentations and omissions" that may have artificially inflated the company's shares and led to a 92% drop in value.
Mako Surgical (NSDQ:MAKO) shareholders have filed 6 lawsuits in the last 4 months, accusing the company of misstating the company's sales and financial outlook in order to artificially inflate its stock value.
The University of Michigan is suing St. Jude Medical, alleging breach of their contract giving St. Jude the exclusive right to a patent covering technology used in St Jude's Epic and Trifecta cardiovascular valves.
The University of Michigan is suing St. Jude Medical (NYSE:STJ), accusing the medical device maker of failing to pay $4.3 million in royalties on sales of St. Jude's Epic and Trifecta cardiovascular valves.